DD262023A5 - Verfahren zur herstellung von dihydropyridinen - Google Patents
Verfahren zur herstellung von dihydropyridinen Download PDFInfo
- Publication number
- DD262023A5 DD262023A5 DD87306414A DD30641487A DD262023A5 DD 262023 A5 DD262023 A5 DD 262023A5 DD 87306414 A DD87306414 A DD 87306414A DD 30641487 A DD30641487 A DD 30641487A DD 262023 A5 DD262023 A5 DD 262023A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- alkyl
- methyl
- formula
- substituted
- chlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dental Preparations (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868620880A GB8620880D0 (en) | 1986-08-29 | 1986-08-29 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD262023A5 true DD262023A5 (de) | 1988-11-16 |
Family
ID=10603368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD87306414A DD262023A5 (de) | 1986-08-29 | 1987-08-27 | Verfahren zur herstellung von dihydropyridinen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4788205A (da) |
| EP (1) | EP0258033B1 (da) |
| JP (1) | JPS6363661A (da) |
| KR (1) | KR880002829A (da) |
| CN (1) | CN87106032A (da) |
| AT (1) | ATE92486T1 (da) |
| AU (1) | AU7767887A (da) |
| DD (1) | DD262023A5 (da) |
| DK (1) | DK450687A (da) |
| FI (1) | FI873725A (da) |
| GB (1) | GB8620880D0 (da) |
| HU (1) | HUT45047A (da) |
| IE (1) | IE872317L (da) |
| IL (1) | IL83681A0 (da) |
| NO (1) | NO873650L (da) |
| PL (1) | PL267485A1 (da) |
| PT (1) | PT85607B (da) |
| ZA (1) | ZA876437B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8712747D0 (en) * | 1987-05-30 | 1987-07-01 | Pfizer Ltd | Therapeutic agents |
| GB8716971D0 (en) * | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Therapeutic agents |
| MY104933A (en) | 1987-09-30 | 1994-07-30 | Pfizer Ltd | Platelet activating factor antagonists |
| US5070205A (en) * | 1987-09-30 | 1991-12-03 | Pfizer Inc. | Alkyl 2-benzylidene-4-(benzimidazol-1-yl) benzoylacetate esters as intermediates |
| GB8803963D0 (en) * | 1988-02-19 | 1988-03-23 | Pfizer Ltd | Therapeutic agents |
| GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
| US5030856A (en) * | 1989-05-04 | 1991-07-09 | International Business Machines Corporation | Receiver and level converter circuit with dual feedback |
| NO912475L (no) * | 1990-06-27 | 1991-12-30 | Sankyo Co | Tiazolidinkarboksylsyreamidderivater med antiallergisk aktivitet, og fremgangsmaate til fremstilling derav. |
| US5470851A (en) * | 1990-06-27 | 1995-11-28 | Sankyo Company, Limited | Thiazolidinecarboxylic acid amide derivatives and their therapeutic uses |
| US5478848A (en) * | 1994-01-26 | 1995-12-26 | Bayer Corporation | Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine |
| US5496855A (en) * | 1995-01-27 | 1996-03-05 | Smithkline Beecham Corp. | Anti-inflammatory compounds |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| US6566359B1 (en) | 2002-05-20 | 2003-05-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| DE102013021933A1 (de) | 2013-12-20 | 2015-06-25 | Skw Stickstoffwerke Piesteritz Gmbh | Verwendung von Pyrazol-Derivaten als Mittel zur Verbesserung der Trockenstresstoleranz |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2210674C3 (de) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
| DE2228377A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE3363743D1 (en) * | 1982-07-22 | 1986-07-03 | Pfizer Ltd | Dihydropyridine anti-ischaemic and antihypertensive agents |
| EP0111453A1 (de) * | 1982-12-10 | 1984-06-20 | Ciba-Geigy Ag | Amid-Verbindungen |
| US4515799A (en) * | 1983-02-02 | 1985-05-07 | Pfizer Inc. | Dihydropyridine anti-ischaemic and antihypertensive agents |
| EP0174131A3 (en) * | 1984-09-01 | 1989-06-07 | FISONS plc | Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them |
-
1986
- 1986-08-29 GB GB868620880A patent/GB8620880D0/en active Pending
-
1987
- 1987-07-20 US US07/075,379 patent/US4788205A/en not_active Expired - Fee Related
- 1987-08-25 AT AT87307494T patent/ATE92486T1/de active
- 1987-08-25 EP EP87307494A patent/EP0258033B1/en not_active Expired - Lifetime
- 1987-08-27 FI FI873725A patent/FI873725A/fi not_active Application Discontinuation
- 1987-08-27 PL PL1987267485A patent/PL267485A1/xx unknown
- 1987-08-27 CN CN198787106032A patent/CN87106032A/zh active Pending
- 1987-08-27 JP JP62214129A patent/JPS6363661A/ja active Pending
- 1987-08-27 DD DD87306414A patent/DD262023A5/de unknown
- 1987-08-27 PT PT85607A patent/PT85607B/pt not_active IP Right Cessation
- 1987-08-28 IL IL83681A patent/IL83681A0/xx unknown
- 1987-08-28 NO NO873650A patent/NO873650L/no unknown
- 1987-08-28 IE IE872317A patent/IE872317L/xx unknown
- 1987-08-28 ZA ZA876437A patent/ZA876437B/xx unknown
- 1987-08-28 HU HU873795A patent/HUT45047A/hu unknown
- 1987-08-28 KR KR870009443A patent/KR880002829A/ko not_active Application Discontinuation
- 1987-08-28 AU AU77678/87A patent/AU7767887A/en not_active Abandoned
- 1987-08-28 DK DK450687A patent/DK450687A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE872317L (en) | 1988-02-29 |
| NO873650L (no) | 1988-03-01 |
| AU7767887A (en) | 1988-03-10 |
| GB8620880D0 (en) | 1986-10-08 |
| FI873725A (fi) | 1988-03-01 |
| ZA876437B (en) | 1989-03-29 |
| CN87106032A (zh) | 1988-03-23 |
| ATE92486T1 (de) | 1993-08-15 |
| EP0258033B1 (en) | 1993-08-04 |
| EP0258033A2 (en) | 1988-03-02 |
| JPS6363661A (ja) | 1988-03-22 |
| NO873650D0 (no) | 1987-08-28 |
| DK450687D0 (da) | 1987-08-28 |
| PT85607A (en) | 1987-09-01 |
| US4788205A (en) | 1988-11-29 |
| PL267485A1 (en) | 1988-09-01 |
| PT85607B (pt) | 1990-05-31 |
| HUT45047A (en) | 1988-05-30 |
| IL83681A0 (en) | 1988-01-31 |
| DK450687A (da) | 1988-03-01 |
| FI873725A0 (fi) | 1987-08-27 |
| KR880002829A (ko) | 1988-05-11 |
| EP0258033A3 (en) | 1990-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD262023A5 (de) | Verfahren zur herstellung von dihydropyridinen | |
| DE60319711T2 (de) | Acylamino-substituierte heteroaromatische verbindungen und ihre verwendung als arzneimittel | |
| AT363096B (de) | Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen | |
| EP0260675A1 (de) | 4-[N-(Substituierte)-amino-phenyl]-substituierte 1,4-Di-(hydro)-pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE4430639A1 (de) | Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten | |
| CH637130A5 (de) | Chinazolin-derivate, verfahren zu ihrer herstellung und verwendung dieser derivate in arzneimitteln. | |
| DE19824175A1 (de) | Amino-azol-Verbindungen | |
| DE2712023A1 (de) | Sulfonamidoaminobenzoesaeurederivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben | |
| EP0217372A2 (de) | Neue polyoxygenierte Labdan-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente | |
| DE4027278A1 (de) | Heterocyclisch substituierte indolsulfonamide | |
| DE3851856T2 (de) | 1,4-Dihydropyridin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DD283996A5 (de) | Verfahren zur herstellung von aminoderivaten | |
| DE3873167T2 (de) | Thiazolidin-4-on-derivate und deren saeure-additionssalze. | |
| EP0018360B1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung | |
| DE3923675A1 (de) | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel | |
| DE3782378T2 (de) | Dihydropyridinderivate und deren pharmazeutische zusammensetzungen. | |
| DE68902064T2 (de) | Dihydropyridine und ihre verwendung als anti-allergische und entzuendungshemmende mittel. | |
| DE4117750A1 (de) | Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
| DD296683A5 (de) | Verfahren zur herstellung von enantiomerenreinen dihydrophyridinamiden | |
| DE68911944T2 (de) | Cardiotonische Alkanoyl- und Aroyloxazole. | |
| EP0110298B1 (de) | Acridanon-Derivate | |
| EP0037471B1 (de) | 1-Aroyl-2-phenylamino-2-imidazoline, ihre Herstellung und diese enthaltende Arzneimittel | |
| DE2062055A1 (de) | Propanolamin Derivate | |
| EP0007643B1 (de) | Oxadiazolotriazinderivate | |
| DE3833893A1 (de) | Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte |